KOR

e-Article

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes
Document Type
Article
Source
In: Diabetes Care. (Diabetes Care, July 2015, 38(7):1181-1188)
Subject
Language
English
ISSN
19355548
01495992